Navigation Links
Kensey Nash to Present at the Canaccord Adams Musculoskeletal Conference
Date:2/13/2009

EXTON, Pa., Feb. 13 /PRNewswire-FirstCall/ -- Kensey Nash Corporation (Nasdaq: KNSY) is scheduled to present at the Canaccord Adams Musculoskeletal Conference at the University of Nevada in Las Vegas on Tuesday, February 24, 2009.

Douglas G. Evans, Kensey Nash's Chief Operating Officer, will deliver the Company's presentation, beginning at approximately 1:00 p.m. (ET). The presentation materials will be available on the company's website (www.kenseynash.com) beginning at 1:00 p.m. (ET) on Tuesday, February 24, 2009. Also, the entire Canaccord Adams Musculoskeletal Conference will be available in an audio-only webcast. To listen to the webcast, you must go to http://www.newswire.ca/en/webcast/viewEvent.cgi?eventID=2550240. The webcast will be made available by the end of the day on Tuesday, February 24, 2009 and be maintained for three months.

About Kensey Nash Corporation. Kensey Nash Corporation is a leading medical technology company providing innovative solutions and technologies for a wide range of medical procedures. The Company provides an extensive range of products into multiple medical markets, primarily sports medicine, spine, and endovascular markets. Many of the products are based on the Company's significant expertise in the design, development, manufacturing and processing of medical devices and absorbable biomaterials, which has led to partnerships to commercialize technologies.


'/>"/>
SOURCE Kensey Nash Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Kensey Nash Corporation Announces its First Quarter 2008 Earnings Release Date and Teleconference
2. Kensey Nash Announces $25 Million Stock Repurchase Program
3. Kensey Nash Reports Acceleration of Stock Awards Triggered by Shareholder Acquisition of Greater Than 20% of Outstanding Shares
4. Kensey Nash Reports First Quarter Fiscal Year 2008 Results
5. Kensey Nash Announces Exclusive License of Optical Guidance Patent to Enhance Chronic Total Occlusion Platform
6. Kensey Nash to Present at the 19th Annual Piper Jaffray Health Care Conference
7. Kensey Nash Corporation Announces Its Second Quarter 2008 Earnings Release Date and Teleconference
8. Kensey Nash Reports Second Quarter EPS of $0.21 and Revenue of $19.6 Million
9. Kensey Nash to Participate in the Sidoti Twelfth Annual New York Emerging Growth Institutional Investor Forum Conference
10. Kensey Nash Reports Third Quarter Record Revenue and Sales
11. Kensey Nash to Present at the Bank of America 2008 Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... Tara Haelle HealthDay ... Binge drinking among young adult men may lead to increased ... drinking didn,t cause a similar rise in blood pressure for ... In fact, when young adult women drank lightly or moderately, ... the study found. "This finding parallels studies in older ...
(Date:10/22/2014)... Dennis Thompson HealthDay Reporter ... officials on Monday officially tightened guidelines for health workers treating ... exposure and use of a respirator at all times. ... issue the tougher rules after two Dallas nurses contracted Ebola ... United States, Liberian national Thomas Eric Duncan. Nina Pham is ...
(Date:10/20/2014)... 20, 2014 With a mere 19 ... Crist made a brief fundraising stop at the ... , Fresh from a debate last night with his ... stage for the first seven minutes because Crist had ... described the incident in one word: "weird." , Before ...
(Date:10/20/2014)... NY (PRWEB) October 20, 2014 ... non-profit organization that helps New Yorkers living with ... changes toward health, housing, recovery and self-sufficiency. Each ... transformed the local community through their tireless efforts. ... Marc Shapses , has been selected as ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 hc1.com ... a secure cloud solution that enables healthcare organizations ... the ultimate healthcare-specific customer relationship management (“CRM”) solution. ... the unique needs of the healthcare industry, the ... for providers and patients by combining healthcare CRM, ...
Breaking Medicine News(10 mins):Health News:Binge Drinking May Boost Blood Pressure in Young Men 2Health News:Binge Drinking May Boost Blood Pressure in Young Men 3Health News:Binge Drinking May Boost Blood Pressure in Young Men 4Health News:CDC Tightens Rules on Caring for Ebola Patients 2Health News:CDC Tightens Rules on Caring for Ebola Patients 3Health News:At Crist Fundraiser, Dan Newlin Says, "No More Robert Germans," Will Seek Changes to Florida Missing Persons Law 2Health News:At Crist Fundraiser, Dan Newlin Says, "No More Robert Germans," Will Seek Changes to Florida Missing Persons Law 3Health News:Savills Studley's Marc Shapses To Be Honored as 2014 "Positive Changemaker" by ASCNYC 2Health News:Savills Studley's Marc Shapses To Be Honored as 2014 "Positive Changemaker" by ASCNYC 3Health News:Healthcare Relationship Management (HRM) Leader hc1.com® Launches hc1® Quick Start™ 2
... who are pre-, perimenopausal with dense breasts benefit most, ... For some women, digital mammography is a better bet ... Women under the age 50 with dense breasts who ... digital mammograms, said study author Dr. Etta Pisano, the ...
... its most selective filter to keep it from clogging with ... St. Louis reveal in a new study. , Researchers ... more vulnerable to dysfunction and disease. , "We speculate ... the filter that can damage it," says senior author Andrey ...
... Xoft, Inc., developer of the,Axxent(R) Electronic ... in,radiation oncology and non-invasive neurosurgery solutions, announced ... agreement., Under the agreement, Elekta will ... Electronic Brachytherapy in the radiation oncology,market. This ...
... Denver Museum of Nature & Science Reveals Plans for New $8 Million ... Interactive Health Science Exhibition ... Jan. 29 Beginning in April 2009, residents and,visitors to the Denver ... their health in ways they have never experienced at a museum,-- or ...
... ... Compliance, and Lowers Costs, NEWARK and EAST BRUNSWICK, N.J., ... empirical,data demonstrating the effectiveness of the Patient Centered Medical Home,(PC-MH), ... their personal physicians and -- when appropriate -- the,patient,s family. ...
... the American Roentgen Ray Society to add more journals ... , BioMed Central, the open access publisher of peer-reviewed ... 4,200 images to the GoldMiner collection. The collection now ... GoldMiner speeds your search for radiology images by quickly ...
Cached Medicine News:Health News:Digital Mammography Better Than Film for Some Women 2Health News:Digital Mammography Better Than Film for Some Women 3Health News:Breakdown of kidney's ability to clean its own filters likely causes disease 2Health News:Breakdown of kidney's ability to clean its own filters likely causes disease 3Health News:Xoft Signs Sales Development Agreement With Elekta 2Health News:Xoft Signs Sales Development Agreement With Elekta 3Health News:Colorado Residents and Visitors to Investigate Health in a Whole New Way 2Health News:Colorado Residents and Visitors to Investigate Health in a Whole New Way 3Health News:Colorado Residents and Visitors to Investigate Health in a Whole New Way 4Health News:Colorado Residents and Visitors to Investigate Health in a Whole New Way 5Health News:Colorado Residents and Visitors to Investigate Health in a Whole New Way 6Health News:Ground Breaking Program Improves Diabetes Patient Outcomes 2Health News:Ground Breaking Program Improves Diabetes Patient Outcomes 3
(Date:10/22/2014)... CITY, Calif. , Oct. 22, 2014 /PRNewswire/ ... today announced that results from the  IAP310 study ... Pain Medicine (RAPM), a peer-reviewed journal with ... Phase 3 trial evaluating the safety and efficacy ... sublingual tablet system (SSTS), for the treatment of ...
(Date:10/22/2014)... Oct. 22, 2014  Regulus Therapeutics Inc. ... company leading the discovery and development of ... it has demonstrated human proof-of-concept with a ... evaluating RG-101, a wholly-owned, GalNac-conjugated anti-miR targeting ... C virus infection ("HCV").  Interim results from ...
(Date:10/20/2014)... , Oct. 20, 2014  PneumRx, Inc. ( ... pulmonology, today announced completion of enrollment in their RENEW ... Clinical Study is the FDA-approved IDE pivotal trial for ... emphysema. It was anticipated that the study, ... 2013, would take until the end of 2014 to ...
Breaking Medicine Technology:AcelRx Announces Publication of Zalviso Phase 3 Abdominal Trial Results 2A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 2A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 3A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 4A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 5A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 6A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 7A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 8PneumRx Completes RENEW Pivotal Trial Enrollment 2PneumRx Completes RENEW Pivotal Trial Enrollment 3
... YORK, March 27 The Michael J. Fox ... million total to seven research teams working to ... awarded under the Foundation,s Improving Delivery of ... program is designed to address two major challenges ...
... March 26 Sleep disordered breathing, also ... National Football League (NFL) players, and particularly in linemen, ... players, adds to the growing body of research examining ... investigators say. The study will be presented Tuesday, March ...
Cached Medicine Technology:Michael J. Fox Foundation Awards $2.1 Million to Improve Drug Delivery in Parkinson's Disease 2Mayo Clinic: Retired National Football League Linemen Have High Incidence of Sleep Apnea 2Mayo Clinic: Retired National Football League Linemen Have High Incidence of Sleep Apnea 3
Vertigraft femoral shaft an large femoral cross-section designed primarily for use in lumbar corpectomy procedures. Freeze dried preservation....
... provides anterior column support for single or ... to L5. The system consists of one ... that are stacked to a desired height, ... fiber reinforced polymer material emulates the biomechanical ...
... bone graft substitute (beta-tricalcium ... Chronos is an advantageous ... It shortens operative time, ... quantity and quality of ...
... bone regeneration scaffold. Its ... composite ensures ideal osteoconductivity, ... structure maximizes permeability even ... the most meaningful measure ...
Medicine Products: